Abstract. Cis-diamminedichloroplatinum (II) cisplatin (CDDP) is an organometallic compound frequently used in anti-cancer therapy, in particular ovarian, testicular, and head and neck tumors. We found cisplatin was effective against human promyelocytic leukemia cell line HL-60, inhibiting cell cycle progression and inducing time-and concentrationdependent cell death. Presence of nuclear fragmentation, caspase-3 cleavage and annexin V positivity suggests cell death occurred by apoptosis, although DNA internucleosomal fragmentation was not detected. In addition, analysis of malondialdehyde (MDA) production and protein carbonylation indicated that cisplatin increased lipid peroxidation and oxidation of cell proteins. This occurrence was prevented by antioxidants such as N-acetylcysteine (N-aC) and glutathione (GSH), which, consistently, were also able to prevent CDDPinduced cell death. Collectively, these findings indicate that, besides growth inhibition, an increase of oxygen radicals and lipid degradation can account for a significant part of CDDPinduced apoptosis.
Introduction
Cisplatin, a potent inducer of growth arrest and/or apoptosis in most cell types has been used clinically for decades against a variety of human malignancies, including ovarian, testicular, bladder, head and neck, esophageal, and small cell lung cancers. Unfortunately, CDDP effects are not restricted to replicating cancer cells, but on the contrary it induces in vivo several adverse drug reactions, including renal, peripheral sensory and autonomic nervous system toxicity. In these systems not only replicating but also non-dividing cells, such as hair cells (HC) and neurons, suffer for cisplatin action, suggesting that a relevant part of its toxicity is mediated by other mechanisms than by merely blocking cell replication. This is consistent with the emerging point of view that the mechanism of action of an antineoplastic drug not only gives increasing importance to the antiproliferative effect, but also considers relevant the apoptosis inducing potential, as a way to restore a cancer-induced apoptotic deficiency. Effectively, in addition to DNA platination, different triggers were proposed to induce cisplatin cytotoxicity, such as oxidative stress or activation of specific intracellular pathways mediating the action of membrane receptors (1, 2) ; the importance of these factors is highlighted by the fact that their modulation allows for the control of cisplatin-dependent apoptosis. It has been shown that increased tolerance to DNA damage as well as antioxidant administration or altered expression of key proteins in signal transduction can increase resistance to cisplatin (3) (4) (5) (6) (7) .
In the present study we examined the mechanism of action of CDDP on human promyelocytic leukemia cells. Our goal is to evaluate the relevance of CDDP-induced oxidative stress in the induction of apoptosis. With this aim, we investigated several morphological and biochemical apoptotic hallmarks (8) , including phosphatidyl serine (PS) exposure on cell surface, activation of one or more proteases of the caspase family, DNA condensation and fragmentation at the nucleosomal level, cell shrinkage and formation of apoptotic bodies in the presence of an intact cell membrane. Subsequently, we quantified lipid degradation and protein oxidation and the extent of antioxidant efficacy in preventing both cell death and reactive oxygen species (ROS) production. maintained in RPMI-1640 (Gibco) supplemented with 10% FCS at a density ranging from 0.3 to 1.5x10 6 cells/ml.
Viability assay. For all the experiments, cells were resuspended at the density of 0.6-1x10 6 cells/ml in fresh medium and challenged with vehicle, CDDP or a combination of CDDP and other drugs. Cell viability was determined by a PI exclusion assay. Briefly, at the end of the incubation period PI at a final concentration of 50 μg/ml was added, the samples were allowed to stand for 15 min at room temperature and then analyzed by flow cytometry (FACStar Becton Dickinson, St. Josè, CA, USA) (9) . Untreated cells were used to identify the PI-low population, while for the PI-bright population, HL-60 cells were permeabilised by adding Nonidet P40 (0.05% final concentration) and then stained with PI and analyzed.
Cell cycle analysis. HL-60, untreated or treated with 50 μM CDDP for 24 h, were collected by centrifugation, washed with phosphate buffered saline (PBS) twice and fixed with 70% ethanol on ice for 30 min, washed again twice with PBS, and incubated for 30 min at 37˚C in presence of 10 μg/ml RNase, DNase-free and 50 μg/ml PI. Samples were successively analyzed by flow cytometry and data were evaluated with CellFIT software (Becton Dickinson).
Annexin V assay. Annexin V assay was performed using the human annexin V-FITC kit from Bender MedSystems (Burlingame, CA).
In situ immunocytochemistry. After treatment, HL-60 were collected by spinning in a cyto spin over a cover slip, washed twice with PBS and then fixed with 4% paraformaldehyde for 30 min at room temperature. Fixed cells were washed with PBS and stained with 2 μg/ml 4,6-diamidino-2-phenylindole (DAPI, Sigma), which selectively stains DNA and allows for the evaluation of nuclear morphology. Slides were mounted with DABCO glycerol and examined under a fluorescence microscope equipped with the appropriate filters (Nikon Eclipse TE 2000-U, Nikitalia, Italy). Table I . Effect of CDDP on the cell cycle. - Table II . PS exposure after CDDP treatment. - Caspase-3 analysis. Western blot analysis of caspase cleavage was carried out as described previously (10) .
DNA analysis. HL-60 cells were treated with different CDDP concentrations for 24 h. Genomic and fragmented DNA was extracted using phenol/chloroform partitioning, analyzed by migration on an agarose gel (2%) at 100 V, and visualized with ethidium bromide staining. As molecular weight markers we used a mix of ÏHindIII (Fermentas) and 100 bp (Invitrogen).
Protein determination. Protein concentration was determined using the bicinchoninic acid assay (BCA), and a 2 mg/ml bovine serum albumin (BSA) solution as standard (Pierce, Rockford, IL) (11).
Evaluation of malondialdehyde (MDA) formation and protein carbonylation products. MDA was assayed as previously reported (9) . Spectrophotometric assay of protein carbonylation products was performed according to a previous report (12) , on samples containing 10-20 μg of protein. Data are presented as the mean ± SD of four replicate samples from at least three separate experiments.
Statistical analysis. Statistical analyzes were performed using the Kruscal-Wallis test, followed by a multiple comparison test. A p-value of <0.05 was considered significant.
Results
After CDDP challenge, HL-60 cells ceased in cycle progression: cells accumulated at the G1 checkpoint, with an increase of the number of cells in G0/G1 phase up to 77.6%, and a parallel reduction of cells present in S and G2/M phase (Table I) . A significant increase in cell toxicity was associated to this stop, as revealed by a viability assay based on PI exclusion. The assay discriminates between viable cells, which can actively extrude PI and are only fairly fluorescent, and damaged or dead cells, which are brightly fluorescent. When we challanged HL-60 cells with increasing concentrations of CDDP for 24 or 48 h, we found a highly significant increase in PI labelling, which indicates a time and concentration dependent drop in membrane integrity (Fig. 1) . Additionally, we found that this indicator of cell death was preceded by more specific and typical hallmarks of apoptosis. Positive labelling with annexin V, which indicated a flipping of phosphatidylserine (PS) from the internal to the external leaflet of cell membrane, occurred after 5 h of treatment and was CDDP concentration-dependent (Table II) . In particular, we found the flipping of PS occurred also in the absence of PI staining (Table II Figure 3 . Effects of CDDP on nuclear morphology. Nuclear morphology was investigated using fluorescent microscopy and DAPI staining, which reveal extensive nuclear fragmentation after 10 μM CDDP for 24 h (A), and transmission electron microscopy, which shows chromatin compaction and nuclear blebbing after 24 h in the presence of 10 μM CDDP (B).
B
artifact due to an undesired staining of intracellular membranes, but can be regarded as an actual early indicator of programmed cell death.
Further confirmation of a prevalence of a programmed cell death path as a primary response to low CDDP concentrations come from the analysis of caspase degradation. We observed at 24 h after 50 μM CDDP treatment the complete disappearance of caspase-3 band (Fig. 2) .
In addition, DAPI staining followed by visual inspection of nuclear morphology under fluorescence microscopy revealed that the cell nuclei underwent deep active changes, fragmenting into several small condensed micronuclei (Fig. 3A) . Transmission electron microscopy (TEM) revealed the presence of cell blebbing, and deep rearrangements of nuclear structure. We observed compaction and margination of chromatin inside nuclear blebs, a preliminary step for nuclear fragmentation into apoptotic bodies. These phenomena occurred in the presence of an intact cell membrane (Fig. 3B) .
On the other hand, we did not find occurrence of internucleosomal fragmentation, which is another typical hallmark of apoptosis. When we separated HL-60 DNA on agarose gel electrophoresis, we observed that CDDP-treated samples failed to generate internucleosomal DNA fragments, showing instead a continuous pattern of DNA fragments apparently starting from 30 kb (Fig. 4) . Appearance of DNA fragments depended upon CDDP concentrations, being maximal at 10 μM, while at higher CDDP concentration all the fragmented DNA was completely lost from the cells after 24 h of incubation (data not shown).
To further characterize the molecular events which prompt CDDP-induced cell death, we used an assay of protein peroxidation to indirectly evaluate the involvement of ROS. This assay measures the amount of carbonyl groups bound to the cell proteins. We found, after CDDP treatment, an increase in protein carbonylation recovery. The increase was detectable from 3 h of cisplatin treatment, significantly peaked at 6 h with a decrease at 10 h, to rise again, and it was time-and CDDP concentration-dependent (Fig. 5) .
Protein carbonylation is an indicator not only by direct oxygen insertion but also by addition of lipid-deriving aldehydes (13) . We tested the hypothesis of lipid peroxidation and breakdown burst by setting a thiobarbituric acid (TBA)-based HPLC assay and quantifying MDA. MDA is an aldehyde-bearing molecule partially responsible for the elevation of carbonylation products, and was expected to increase in a time shorter than the carbonylation products. Consistently, MDA showed a peak at 3 h after platinum challenge (Fig. 6) .
The importance of an oxidative step in CDDP-induced cell death was further strengthened by the use of antioxidants such as N-aC and GSH. These compounds were able not only to revert protein carbonylation (Fig. 7) , but overall to significantly reduce the extent of cell death (Fig. 8) , strongly supporting the possibility for a pivotal role of ROS in the CDDP-induced apoptosis.
Discussion
Cisplatin is a chemotherapeutic molecule believed to exert its toxic activity both through necrosis and apoptosis. In HL-60 we demonstrate its ability to induce a time and concentration dependent cell death, which, in the low micromolar range of toxicity (below 100 μM CDDP), occurs by apoptosis. Actually, we can detect several coordinated events, like as caspase proteolysis, membrane exposure of PS, which occurred also in absence of other membrane damages, and deep nuclear changes. These included nuclear blebbing and fragmentation, together with chromatin compaction and margination inside nuclear blebs. Additionally, cell DNA was cleaved into both high and low molecular weight fragments in a CDDP concentration-dependent manner, probably through an aspecific nuclease activity.
Cisplatin can elicits its cytotoxic effect using several different routes: genotoxicity is perhaps the best characterized, but not unique or the most relevant in the exploitation of antitumor activity. Cisplatin is able to react with functional residues of proteins and low-molecular weight molecules (14) . In this way it gives rise to a wide number of different platination products, affects in the same time multiple cellular functions and intracellular pathways, and suggests the antineoplastic activity can derive from the interaction of several cytotoxic activities. In the present study, we note that its dose-and time-dependent toxicity can be related at least to two different mechanisms. Cisplatin was able to block cell cycle progression, a finding consistent with its reported capacity to originate inter-and intrastrand cross links, and ultimately to interfere with binding and action of transcription factors and other members of the replicative machinery.
In addition to the genotoxic activity, a second relevant route can be detected. We observed CDDP significantly increases the amount of reactive aldehydes. Several lipid peroxides such as hydroperoxyeicosatetraenoic acids (HPETEs), alkenals and hydroxy alkenals, including HNE and MDA, are formed during physiological events or oxidative bursts (15) . These endogenous aldehydes can react with cellular proteins introducing a carbonylic group exposed on the protein surface, giving rise to an increase of carbonylation products.
In CDDP-treated HL-60, the increase of free aldehydes and bound carbonylic groups occurred both in a biphasic fashion. We detected at 3 and 6 h after treatment a significant increase of MDA and carboxylation products; both decreased at a later time, to rise again at 24-48 h, during the onset of cell death. While the late increase of aldehydes and carbonylation products can simply indicate the occurrence of necrotic postapoptotic oxidation of the lipidic and proteic compartment, the first peak of aldehydes and carbonylation products, which appeared soon after CDDP challenge, indicates the presence of a significant early oxidative damage of cell membranes and proteins. These events are known to trigger cell death (16, 17) .
Consistently with the hypothesis of a triggering role for oxidative events we found that N-aC and GSH not only were able to completely prevent protein carbonylation, but they significantly although not completely prevent cell death. Antioxidants suppress the peak of aldehydes and carbonylation products occurring at 3-6 h, and eliminate in a concentrationdependent manner a significant part of cisplatin-induced cell death, leaving probably only the genotoxic-induced death. The fact that extracellular GSH is not a cell permeant does not affect its capacity to increase intracellular reducing power. It can be extracellularly cleaved and the resulting amino acids can be internalized and used in GSH resynthesis.
These findings, together with the fact that cisplatin can decrease the intracellular GSH concentration (18) , allowing for a intracellular burst of oxidative events, suggest that part of toxic action of cisplatin is due to an increase of intracellular ROS. In conclusion, our study proves the ability of CDDP to induce a time-and dose-concentration-dependent apoptosis, highlighting the ability of GSH and N-aC to suppress CDDPdependent peroxidation of lipids and carbonylation of proteins. This prevents part of of CDDP-induced cell death and prompts the hypothesis of involvement of ROS in cisplatin-induced apoptosis, suggesting that lipid and protein oxidation products can be an early marker of this event.
